Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 7 Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Glioblastoma 2 Esophageal Squamous Cell Carcinoma 2 Advanced Solid Tumors 2 von Hippel-Lindau Disease 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomach Adenocarcinoma 1 Solid Tumors 1 Solid Tumor, Adult 1 Solid Tumor 1

Interventions

Leucovorin 2 Irinotecan 2 Fluorouracil 2 spartalizumab 1 pembrolizumab 1 Radiosurgery 1 Oxaliplatin 1 Oncolytic Virotherapy 1 IFL protocol 1 Folfox protocol 1 Drug Therapy 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

CRC × spartalizumab × 1 year × Clear all

NCT07381309 2026-04-28

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡